Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Endo Health Solutions Inc (ENDP)  
$0.00 0.00 (0.00%) as of 4:30 Tue 4/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 230,290,000
Market Cap: 138.17(K)
Last Volume: 11,847,187 Avg Vol: 11,814,278
52 Week Range: $0.0001 - $0.066
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 825
  Page 10 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Sweeney Edward J Principal Accounting Officer   •       –      –    2011-02-28 4 OE $0.00 $0 D/D 1,110 1,110     -
   Gergel Ivan EVP, Research & Development   •       –      –    2011-02-24 4 AS $33.59 $528,774 D/D (15,742) 0     -
   Gergel Ivan EVP, Research & Development   •       –      –    2011-02-24 4 OE $20.61 $324,443 D/D 15,742 15,742     -
   Gergel Ivan EVP, Research & Development   •       –      –    2011-02-23 4 OE $0.00 $0 D/D 13,316 13,316     -
   Mchugh Julie Chief Operating Officer   •       –      –    2011-02-23 4 OE $0.00 $0 D/D 15,745 15,745     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2011-02-23 4 OE $0.00 $0 D/D 16,368 16,368     -
   Manogue Caroline B Exec. V.P., CLO & Secy   •       –      –    2011-02-23 4 OE $0.00 $0 D/D 11,732 11,732     -
   Holveck David President & CEO   •       •      –    2011-02-23 4 OE $0.00 $0 D/D 51,913 51,913     -
   Sweeney Edward J Principal Accounting Officer   •       –      –    2011-02-21 4 S $32.34 $22,476 D/D (695) 0     -
   Sweeney Edward J Principal Accounting Officer   •       –      –    2011-02-21 4 OE $0.00 $0 D/D 695 695     -
   Sweeney Edward J Principal Accounting Officer   •       –      –    2011-02-19 4 S $32.34 $37,838 D/D (1,170) 0     -
   Sweeney Edward J Principal Accounting Officer   •       –      –    2011-02-19 4 OE $0.00 $0 D/D 1,170 1,170     -
   Spengler William Director   –       •      –    2010-12-31 4 A $0.00 $0 D/D 854 14,771     -
   Montague William P Director   –       •      –    2010-12-31 4 A $0.00 $0 D/D 406 10,385     -
   Scodari Joseph C Director   –       •      –    2010-12-31 4 A $0.00 $0 D/D 252 15,412     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2010-12-13 4/A OE $20.09 $99,988 D/D 4,977 11,554     -
   Kimmel Roger H Director   –       •      –    2010-12-10 4 S $36.55 $502,234 D/D (13,741) 191,853     -
   Kimmel Roger H Director   –       •      –    2010-12-10 4 OE $11.00 $245,391 D/D 13,741 205,594     -
   Hutson Nancy J Director   –       •      –    2010-12-07 4 B $36.38 $36,380 I/I 1,000 1,000 2.1     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2010-12-07 4 OE $16.51 $374,500 D/D 21,604 11,554     -
   Levin Alan G EVP, Chief Financial Officer   •       –      –    2010-12-07 4 S $36.04 $599,237 D/D (16,627) 6,577     -
   Gergel Ivan EVP, Research & Development   •       –      –    2010-12-03 4 S $36.53 $2,031,178 D/D (55,603) 0     -
   Gergel Ivan EVP, Research & Development   •       –      –    2010-12-03 4 OE $19.93 $1,235,418 D/D 55,603 55,603     -
   Hyatt Michael Director   –       •      –    2010-12-03 4 S $36.43 $364,300 D/D (10,000) 247,605     -
   Hyatt Michael Director   –       •      –    2010-12-03 4 OE $6.88 $68,800 D/D 10,000 257,605     -

  825 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed